Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
AP correspondent Jackie Quinn reports on a new benefit linked to a popular weight-loss drug
Key takeaways Standard treatments for binge eating disorder focus on addressing the underlying emotions, but may not always be enough to manage weight in some people
Subcutaneous Injection Technique: Subcutaneous injections deliver the peptide into the fatty tissue layer between skin and muscle, allowing for gradual absorption into the bloodstream
Assessing the real-world effect of semaglutide and tirzepatide on weight loss provides a glimpse into what we may see with the recently approved obesity drug tirzepatide (brand name Zepbound) and how it might compare with semaglutide (brand name Wegovy)
If you're taking Wegovy, Ozempic, or a self-administered compounded semaglutide you inject subcutaneously, the dosing schedule is once weekly
It binds 9 times its weight of fat and also reduces daily caloric absorption by up to 500 calories
